Issue navigation
Volume 112, Issue 5, May 2020
Editorials
Basing Eligibility for Lung Cancer Screening on Individualized Risk Calculators Should Save More Lives, but Life Expectancy Matters
Hormuzd A Katki and others
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 429–430, https://doi.org/10.1093/jnci/djz165
Understanding the Time Course of Cancer-Associated Cognitive Decline: Does Impairment Precede Diagnosis?
Brent J Small and Heather S L Jim
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 431–432, https://doi.org/10.1093/jnci/djz179
Choosing Breast Cancer Risk Models: Importance of Independent Validation
Mitchel H Gail
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 433–435, https://doi.org/10.1093/jnci/djz180
Talking the Talk About Tumor Genomic Testing
Richard L Schilsky
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 436–437, https://doi.org/10.1093/jnci/djz175
Commentary
Lack of Availability and Efficacy of Phase I and Basket Trials for Patients With Gastrointestinal Cancers
Rajiv Agarwal and others
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 438–442, https://doi.org/10.1093/jnci/djz228
Review
Interventions to Enhance Adherence to Oral Antineoplastic Agents: A Scoping Review
Shoshana M Rosenberg and others
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 443–465, https://doi.org/10.1093/jnci/djz244
Articles
A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies
Kevin ten Haaf and others
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 466–479, https://doi.org/10.1093/jnci/djz164
Trajectories of Cognitive Function Prior to Cancer Diagnosis: A Population-Based Study
Kimberly D van der Willik and others
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 480–488, https://doi.org/10.1093/jnci/djz178
Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort
Anne Marie McCarthy and others
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 489–497, https://doi.org/10.1093/jnci/djz177
Factors Associated With Oncologist Discussions of the Costs of Genomic Testing and Related Treatments
K Robin Yabroff and others
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 498–506, https://doi.org/10.1093/jnci/djz173
Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma
Minjie Gao and others
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 507–515, https://doi.org/10.1093/jnci/djz159
Prediagnostic Plasma Bile Acid Levels and Colon Cancer Risk: A Prospective Study
Tilman Kühn and others
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 516–524, https://doi.org/10.1093/jnci/djz166
Radiation Dose and Volume to the Pancreas and Subsequent Risk of Diabetes Mellitus: A Report from the Childhood Cancer Survivor Study
Danielle Novetsky Friedman and others
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 525–532, https://doi.org/10.1093/jnci/djz152
Melanoma Incidence Among Non-Hispanic Whites in All 50 US States From 2001 Through 2015
Aaron P Thrift and Franciska J Gudenkauf
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 533–539, https://doi.org/10.1093/jnci/djz153
Brief Communication
Modeling Breast Cancer Using CRISPR-Cas9–Mediated Engineering of Human Breast Organoids
Johanna F Dekkers and others
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 540–544, https://doi.org/10.1093/jnci/djz196
Correspondence
Re: Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population
Hyuna Sung and others
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 545–546, https://doi.org/10.1093/jnci/djz190
Response to Sung, Rosenberg, and Yang
Ching-hung Lin and others
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Pages 547–548, https://doi.org/10.1093/jnci/djz191
Corrigenda
Corrigendum
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Page 549, https://doi.org/10.1093/jnci/djz204
Corrigendum
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 5, May 2020, Page 550, https://doi.org/10.1093/jnci/djaa006
Advertisement
Advertisement